Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.440, 2003-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CAP care costs in Spain hefty, but could be contained
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 453, 2004-01 ,pp. :
Access to resources
Recommend
Metoclopramide, sumatriptan for migraine treatment in the ED
Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. :
Almotriptan cost beneficial for migraine in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. :
Valuing the lost productivity of migraine in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
The Burden of Migraine in Spain: Beyond Direct Costs
By Badia X.
PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. :